[go: up one dir, main page]

BR0307469A - Derivados de fenilglicina solúveis em água - Google Patents

Derivados de fenilglicina solúveis em água

Info

Publication number
BR0307469A
BR0307469A BR0307469-2A BR0307469A BR0307469A BR 0307469 A BR0307469 A BR 0307469A BR 0307469 A BR0307469 A BR 0307469A BR 0307469 A BR0307469 A BR 0307469A
Authority
BR
Brazil
Prior art keywords
water soluble
derivatives
phenylglycine derivatives
factor
soluble
Prior art date
Application number
BR0307469-2A
Other languages
English (en)
Inventor
Leo Alig
Katrin Groebke Zbinden
Ulrike Obst
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0307469A publication Critical patent/BR0307469A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)

Abstract

"DERIVADOS DE FENILGLICINA SOLúVEIS EM áGUA". A presente invenção refere-se aos novos derivados de N-(4carbamimidoil-fenil)-glicina solúveis em água da Fórmula (I); em que R^ 1^ a R^ 4^ e n são como definidos na descrição e nas reivindicações, como também seus sais fisiologicamente aceitáveis. Estes compostos inibem a formação de fatores de coagulação Xa, IXa e trombina induzida por fator Vila e fator de tecido e podem ser usados como medicamentos.
BR0307469-2A 2002-02-06 2003-01-30 Derivados de fenilglicina solúveis em água BR0307469A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02002009 2002-02-06
PCT/EP2003/000937 WO2003066588A1 (en) 2002-02-06 2003-01-30 Water soluble phenylglycine derivatives

Publications (1)

Publication Number Publication Date
BR0307469A true BR0307469A (pt) 2004-11-09

Family

ID=27675597

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307469-2A BR0307469A (pt) 2002-02-06 2003-01-30 Derivados de fenilglicina solúveis em água

Country Status (19)

Country Link
US (1) US6642386B2 (pt)
EP (1) EP1474391A1 (pt)
JP (1) JP2005522435A (pt)
KR (1) KR20040082411A (pt)
CN (1) CN1628099A (pt)
AR (1) AR038480A1 (pt)
AU (1) AU2003244474B2 (pt)
BR (1) BR0307469A (pt)
CA (1) CA2474027A1 (pt)
GT (1) GT200300030A (pt)
JO (1) JO2241B1 (pt)
MX (1) MXPA04007500A (pt)
PA (1) PA8564801A1 (pt)
PE (1) PE20030905A1 (pt)
PL (1) PL372197A1 (pt)
RU (1) RU2283305C2 (pt)
TW (1) TW200303744A (pt)
UY (1) UY27653A1 (pt)
WO (1) WO2003066588A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035858A1 (en) * 1998-12-14 2000-06-22 F. Hoffmann-La Roche Ag Phenylglycine derivatives
WO2004072102A2 (en) 2003-02-11 2004-08-26 Bristol-Myers Squibb Company Benzene acetamide compounds useful as serine protease inhibitors
US7122559B2 (en) 2003-02-11 2006-10-17 Bristol-Myers Squibb Company Phenylglycine derivatives useful as serine protease inhibitors
DE602006016566D1 (de) 2005-01-10 2010-10-14 Bristol Myers Squibb Co Als antikoagulanzien verwendbare phenylglycinamid-derivate
WO2007002313A2 (en) * 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035858A1 (en) 1998-12-14 2000-06-22 F. Hoffmann-La Roche Ag Phenylglycine derivatives
US6548694B2 (en) 2000-05-23 2003-04-15 Hoffman-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives

Also Published As

Publication number Publication date
RU2283305C2 (ru) 2006-09-10
RU2004126940A (ru) 2005-08-10
PL372197A1 (en) 2005-07-11
US6642386B2 (en) 2003-11-04
AU2003244474A1 (en) 2003-09-02
AU2003244474B2 (en) 2006-05-11
UY27653A1 (es) 2003-08-29
EP1474391A1 (en) 2004-11-10
CA2474027A1 (en) 2003-08-14
US20030166683A1 (en) 2003-09-04
KR20040082411A (ko) 2004-09-24
PE20030905A1 (es) 2003-11-08
JO2241B1 (en) 2004-10-07
CN1628099A (zh) 2005-06-15
JP2005522435A (ja) 2005-07-28
WO2003066588A1 (en) 2003-08-14
GT200300030A (es) 2003-09-12
AR038480A1 (es) 2005-01-19
PA8564801A1 (es) 2003-12-10
MXPA04007500A (es) 2004-11-10
TW200303744A (en) 2003-09-16

Similar Documents

Publication Publication Date Title
BR0316508A (pt) Derivados de ácido mandélico
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
CY1106375T1 (el) Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας
MEP10408A (en) Platinum derivative pharmaceutical formulations
BR9916111A (pt) Derivados de fenilglicina
BRPI0517999A (pt) derivados de tetraidropirano como antidiabéticos
BR0007781A (pt) Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf
BR0110998A (pt) Derivados de fenilglicina
BR0206501A (pt) Inibidores de cruzipaìna e outras cisteìna proteases
MEP35208A (bs) Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju
BRPI0515140A (pt) derivados de benzamidina de 4-aminometila e seu emprego como inibidores do fator viia
BR0311646A (pt) Derivados de ácido n-benzoilureido cinâmico, processo para sua preparação e seu emprego
BR0307469A (pt) Derivados de fenilglicina solúveis em água
BR0315320A (pt) Composto ou sais farmaceuticamente aceitáveis dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de dor em um animal de sangue quente e para produzir um composto
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
UY29896A1 (es) Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
BRPI0417274A (pt) n-(4-carbamimidoilbenzil)-2-alcóxi-2-heterociclilacet amidas como inibidores da formação de fatores de coagulação xa, ixa, e trombina induzida pelo fator viia
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
BRPI0403909A (pt) Solução aquosa de tensoativos anfotéricos altamente concentrada
BR0214104A (pt) Oligopeptìdeos e composições contendo os mesmos como inibidores de catepsina
DK1411956T3 (da) Anvendelse af oversulfaterede polysaccharider som inhibitorer af HIV
SE0201938D0 (sv) New process

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A., E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.